Ponisio M, Zempel J, Willie J, Tomko S, McEvoy S, Roland J
Pediatr Radiol. 2024; 54(10):1589-1602.
PMID: 39123082
DOI: 10.1007/s00247-024-06011-6.
Kamp A, Andersson M, Leide-Svegborn S, NoBke D, Mattsson S, Giussani A
EJNMMI Phys. 2023; 10(1):10.
PMID: 36752876
PMC: 9908780.
DOI: 10.1186/s40658-023-00528-9.
April G, De Bruycker J, Decaluwe H, Haddad E, Lambert R, Turpin S
Ann Nucl Med. 2022; 36(7):661-673.
PMID: 35643969
DOI: 10.1007/s12149-022-01748-2.
Zheng C, Holden D, Zheng M, Pracitto R, Wilcox K, Lindemann M
Eur J Nucl Med Mol Imaging. 2021; 49(5):1482-1496.
PMID: 34761284
PMC: 8940841.
DOI: 10.1007/s00259-021-05597-5.
Kirchner J, ODonoghue J, Becker A, Ulaner G
EJNMMI Phys. 2021; 8(1):6.
PMID: 33469848
PMC: 7815860.
DOI: 10.1186/s40658-021-00352-z.
A pilot study treatment of malignant tumors using low-dose F-fluorodeoxyglucose (F-FDG).
Paul D, Ghiuzeli C, Rini J, Palestro C, Fung E, Ghali M
Am J Nucl Med Mol Imaging. 2020; 10(6):334-341.
PMID: 33329935
PMC: 7724279.
Imaging Cardiovascular and Lung Macrophages With the Positron Emission Tomography Sensor Cu-Macrin in Mice, Rabbits, and Pigs.
Nahrendorf M, Hoyer F, Meerwaldt A, van Leent M, Senders M, Calcagno C
Circ Cardiovasc Imaging. 2020; 13(10):e010586.
PMID: 33076700
PMC: 7583675.
DOI: 10.1161/CIRCIMAGING.120.010586.
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?.
Dejaco D, Uprimny C, Widmann G, Riedl D, Moser P, Arnold C
Cancer Imaging. 2020; 20(1):69.
PMID: 32993805
PMC: 7526367.
DOI: 10.1186/s40644-020-00345-8.
Human Radiation Dosimetry for Orally and Intravenously Administered F-FDG.
Srinivasan S, Crandall J, Gajwani P, Sgouros G, Mena E, Lodge M
J Nucl Med. 2019; 61(4):613-619.
PMID: 31628217
PMC: 9374043.
DOI: 10.2967/jnumed.119.233288.
Evaluation of cell viability and metabolic activity of a 3D cultured human epidermal model using a dynamic autoradiographic technique with a PET radiopharmaceutical.
Sasaki T, Tamaki J, Nishizawa K, Kojima T, Tanaka R, Moriya R
Sci Rep. 2019; 9(1):10685.
PMID: 31337856
PMC: 6650402.
DOI: 10.1038/s41598-019-47153-0.
Dose Reduction in Brain [F]FDG PET/MRI: Give It Half a Chance.
Soret M, Piekarski E, Yeni N, Giron A, Maisonobe J, Khalife M
Mol Imaging Biol. 2019; 22(3):695-702.
PMID: 31286349
DOI: 10.1007/s11307-019-01398-3.
Light-Induced Pupillary Responses in Alzheimer's Disease.
Chougule P, Najjar R, Finkelstein M, Kandiah N, Milea D
Front Neurol. 2019; 10:360.
PMID: 31031692
PMC: 6473037.
DOI: 10.3389/fneur.2019.00360.
Biodistribution, Tumor Detection, and Radiation Dosimetry of F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors.
Young C, Adler S, Eary J, Lindenberg M, Jacobs P, Collins J
J Nucl Med. 2018; 60(4):492-496.
PMID: 30389817
PMC: 6448462.
DOI: 10.2967/jnumed.118.216994.
Re-evaluation of pediatric F-FDG dosimetry: Cristy-Eckerman versus UF/NCI hybrid computational phantoms.
Khamwan K, OReilly S, Plyku D, Goodkind A, Josefsson A, Cao X
Phys Med Biol. 2018; 63(16):165012.
PMID: 30022768
PMC: 6398606.
DOI: 10.1088/1361-6560/aad47a.
Update on F-Fluciclovine PET for Prostate Cancer Imaging.
Parent E, Schuster D
J Nucl Med. 2018; 59(5):733-739.
PMID: 29523631
PMC: 6910635.
DOI: 10.2967/jnumed.117.204032.
Reduction of Radiation Exposure to Patients and Professionals by Reducing the Administered Activity of 18F-Fluorodeoxyglucose in a Positron-emission Tomography/Computed Tomography Study.
Mithun S, Jha A, Puranik A, Monteiro P, Shah S, Agarwal A
Indian J Nucl Med. 2018; 33(1):6-9.
PMID: 29430107
PMC: 5798103.
DOI: 10.4103/ijnm.IJNM_103_17.
Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.
Michelhaugh S, Muzik O, Guastella A, Klinger N, Polin L, Cai H
J Nucl Med. 2016; 58(2):208-213.
PMID: 27765857
PMC: 5288739.
DOI: 10.2967/jnumed.116.179994.
Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
Quinn B, Dauer Z, Pandit-Taskar N, Schoder H, Dauer L
BMC Med Imaging. 2016; 16(1):41.
PMID: 27317478
PMC: 4912712.
DOI: 10.1186/s12880-016-0143-y.
Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
Nilica B, Waitz D, Stevanovic V, Uprimny C, Kendler D, Buxbaum S
Eur J Nucl Med Mol Imaging. 2016; 43(9):1585-92.
PMID: 26922350
PMC: 4932132.
DOI: 10.1007/s00259-016-3328-2.
Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.
Kaushik A, Jaimini A, Tripathi M, Dsouza M, Sharma R, Mondal A
Indian J Med Res. 2016; 142(6):721-31.
PMID: 26831421
PMC: 4774069.
DOI: 10.4103/0971-5916.174563.
